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Children’s Health Article
The Children’s Health Act of 2000 authorized
the National Children’s Study (NCS), a large,
multiagency, long-term study of environmen-
tal inﬂuences on children’s health and develop-
ment (Children’s Health Act 2000). The NCS
will examine about 100,000 children across
the United States and follow them during
prenatal development, through birth and
childhood, and into adulthood (Branum et
al. 2003). The NCS Exposure to Chemical
Agents Working Group has identified non-
persistent pesticides, including synthetic 
pyrethroid and organophosphate pesticides
(OPs), as chemical classes of study for poten-
tial adverse neurodevelopmental outcomes
(National Children’s Study 2001). The use of
biomarkers to determine absorbed doses of
environmental chemicals such as OPs is a
critical issue for implementing the NCS.
OPs became widely used as the environ-
mentally persistent organochlorine pesticides
were banned in the 1970s. OPs gained popu-
larity in the early 1980s because they were
relatively inexpensive, readily available, less
persistent in the environment, and less sus-
ceptible to pest resistance. OPs are used pri-
marily in agriculture on crops, but are also
used in residential settings for pest control
and for public health protection against vec-
tor-borne diseases (Table 1). Approximately
60 million pounds of OPs are applied to U.S.
crops annually; nonagricultural uses account
for an additional 17 million pounds [U.S.
Environmental Protection Agency (U.S.
EPA) 1999]. A survey conducted for the U.S.
EPA found that nearly half of U.S. house-
holds with a child younger than 5 years had a
pesticide stored within reach of children
(Whitmore et al. 1992). OPs account for
about half of all insecticides used in the
United States by amount sold. In outdoor
settings, OPs are relatively nonpersistent
because they are degraded by photochemical
and microbiologic actions. However, when
used indoors or as a part of structural treat-
ments, these compounds can remain stable
for extended periods of time (i.e., months to
years; Fenske et al. 2000) and can remain
potentially available for repeated exposure to
both adults and children.
The safety of OPs has come under increas-
ing scrutiny after the release of the National
Research Council’s (1993) report focusing on
dietary pesticide exposure among infants and
children. Consequently, passage of the Food
Quality Protection Act of 1996 led the U.S.
EPA to consider childhood pesticide exposure
in aggregate and reassess all pesticide residue
tolerances (Food Quality Protection Act
1996). OPs were the first class of pesticides
whose tolerances were reassessed because of
their common mode of toxicity, widespread
use, and unknown long-term health effects.
Because of increasing concern regarding the
safety of these pesticides to children, many OP
uses are being phased out (Table 1).
Acute effects of OP exposures are well
documented and well understood (Kwong
2002). Because they are powerful inhibitors of
carboxylic ester hydrolases, including acetyl-
cholinesterase (AChE; found in nerve tissues
and erythrocytes) and butyrylcholinesterase
(plasma or pseudocholinesterase), individuals
exposed to high levels of OPs can develop
acute cholinergic syndrome, which is charac-
terized by a variety of symptoms including rhi-
norrhea, salivation, lachrymation, tachycardia,
headache, convulsions, and death (Karalliedde
et al. 2001). In addition, these individuals can
also develop a proximal and reversible paralysis
called intermediate syndrome, organophos-
phate-induced delayed polyneuropathy, or
long-term neurologic sequelae. Although
adverse effects of chronic low-level OP expo-
sure are suspected, they have not been conclu-
sively determined (Eskenazi et al. 1999; Ray
and Richards 2001).
Because exposure to OPs is multiroute and
the dominant route of childhood exposure
depends on a variety of dietary and behavioral
factors, quantiﬁcation of exposure is not a triv-
ial process. Therefore, in many epidemiologic
studies, markers of exposure in biologic sam-
ples have been measured to provide an estima-
tion of absorbed dose (Aprea et al. 2000;
Heudorf and Angerer 2001; Loewenherz et al.
1997; Lu et al. 2001; Mills and Zahm 2001;
Moate et al. 1999; O’Rourke et al. 2000;
Whyatt and Barr 2001). Although blood and
urine are the primary human specimens that
have been used for biologic monitoring of OP
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Because of their history of widespread use in the United States and unknown long-term health effects,
organophosphate pesticides (OPs) are being considered as a chemical class of interest in planning for
the National Children’s Study, a longitudinal study of children’s environmental health. The availabil-
ity and appropriate use of biomarkers to determine absorbed doses of environmental chemicals such as
OPs are critical issues. Biomarkers of OP exposure are typically measured in blood and urine; how-
ever, postpartum meconium has been shown to be a promising matrix for assessing cumulative in
utero exposure to the fetus, and studies are currently in progress to determine the utility of using saliva
and amniotic ﬂuid as matrices. In this article, we discuss the advantages and disadvantages of the cur-
rently available OP exposure monitoring methods (cholinesterase inhibition in blood, pesticides in
blood, metabolites in urine and alternative matrices); study design issues for a large, long-term study
of children’s environmental health; and current research and future research needs. Because OPs are
rapidly metabolized and excreted, the utility of one-time spot measurements of OP biomarkers is
questionable unless background exposure levels are relatively stable over time or a speciﬁc time frame
of interest for the study is identiﬁed and samples are collected accordingly. Biomarkers of OP expo-
sure can be a valuable tool in epidemiology of children’s environmental health, as long as they are
applied and interpreted appropriately. Key words: biomarkers, blood, children, exposure, meconium,
organophosphate, pesticides, study design, urine. Environ Health Perspect 111:1939–1946 (2003).
doi:10.1289/ehp.6179 available via http://dx.doi.org/ [Online 10 September 2003]exposure, postpartum meconium has been
shown to be a promising matrix for assessing
cumulative in utero exposures to the fetus, and
studies are in progress to determine the utility
of using saliva and amniotic ﬂuid as matrices
(Bradman et al. 2003; Whyatt and Barr 2001).
OP Metabolism
Our ability to incorporate biomarkers of OPs
successfully into epidemiologic studies depends
on our knowledge of OP metabolism. OPs all
have the same general structure and mode of
toxicity (Mileson et al. 1998). They are com-
posed of a phosphate (or phosphorothioate or
phosphorodithioate) moiety, which in most
cases is O,O-dialkyl substituted, where the
alkyl groups are either dimethyl or diethyl; and
an organic group that is speciﬁc to each pesti-
cide (Figure 1). For instance, chlorpyrifos is
composed of an O,O-diethyl phosphorothioate
to which a 3,5,6-trichloropyridinyl group is
attached. Once entering the body, OPs can be
enzymatically converted to their oxon form
and then react with available cholinesterase.
The oxon can also be enzymatically or sponta-
neously hydrolyzed to form a dialkyl phos-
phate (DAP) metabolite and a specific
metabolite moiety. In the case of chlorpyrifos,
diethylphosphate and 3,5,6-trichloro-2-pyri-
dinol (TCPY) are formed. If the pesticide is
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Table 1. Common OPs, their metabolites, and uses, with implications for biomarker assessment in children.
Speciﬁc OP Analysis of
Pesticides DMP DMTP DMDTP DEP DETP DEDTP metabolites OP in blood Insecticidal usesa
Acephate — — — — — — Acephate, — Crops, food handling, methamidophos ornamentals, 
methamidophos residential
Azinphos-methyl X X X — — — BTA, MSMB — Crops, trees, ornamentals.
Bensulide — — — — — — — — Crops, lawn/turf, ornamental
Cadusafos — — — — — — — — Import tolerances only (bananas)
Chlorethoxyphos — — — X X — — — Crops (corn)
Chlorpyrifos — — — X X — 3,5,6-TCPY X Crop, lawn/turf, termiticide,
ornamentals, pasture, livestock
Chlorpyrifos-methyl X X — — — — 3,5,6-TCPY — Stored grain; undergoing voluntary cancellation
(2004 for use, 2008 for tolerances)
Coumaphos — — — X X — CMHC — Livestock
Diazinon — — — X X — IMPY X Crop, lawn/turf, residential/commercial; residential 
uses being phased out
Dichlorvos (DDVP) X — — — — — — X Pest strips, residential, food, storage/processing, 
livestock
Dicrotophos X — — — — — — — Crops (cotton), trees
Dimethoate X X X — — — — — Crops, ornamentals
Disulfoton — — — X X X — — Crops, ornamentals
Ethion — — — X X X — — Crops (citrus), livestock; undergoing
voluntary cancellation
Ethoprop — — — — — — — — Crops, ornamentals, trees
Ethyl parathion — — — X X — p-Nitrophenol X Crops; undergoing voluntary cancellation (by 2003)
Fenamiphos — — — — — — — — Crops, ornamental, turf; undergoing voluntary
cancellation (by 2007)
Fenitrothion X X — — — — — — Residential/commercial ant/roach bait; imported wheat
(Australia)
Fenthion X X — — — — — — Livestock, mosquito control (Florida)
Malathion X X X — — — Malathion X Crops, livestock, lawn/turf, mosquito
dicarboxylic acid; 
Malathion mono- 
carboxylic acid
Methamidophos — — — — — — Methamidophos — Crops
Methidathion X X X — — — — — Crops, ornamentals
Methyl parathion X X — — — — p-Nitrophenol X Crops
Mevinphos X — — — — — — — Import tolerances only
Naled X — — — — — — — Crops, greenhouse
Oxydemeton-methyl X X — — — — — — Crops
Phorate — — — X X X — X Crops
Phosalone — — — X X X — — Import tolerances only
Phosmet X X X — — — — — Crops, ornamental, forestry, livestock
Phostebupirim — — — — — — — — Crops (corn)
(tebupirimphos)
Pirimiphos-methyl X X — — — — DEAMPY — Stored corn, seed, grain, livestock, bulbs
Profenofos — — — — — — — — Crops (cotton)
Propetamphos — — — — — — — — Indoor ant control
Sulfotepp — — — X X — — — Greenhouses, ornamental; undergoing voluntary 
cancellation (by ~2004)
Temephos X X — — — — — — Mosquito larva
Terbufos X X X X Crops
Tetrachlorvinphos X — — — — — — — Livestock, domestic animals 
(dogs/cats)
Tribufos — — — X X — — — Crops (cotton)
Trichlorfon X — — — — — — — Ornamentals, turf, agricultural premises, nurseries, ants
Abbreviations: —, not applicable; BTA, 1,2,3-benzotriazin-4(3H)-one/ol; CIT, 5-chloro-1-isopropyl-(1H)-1,2,4-triazol-3-ol/one; CMHC, 3-chloro-7-hydroxy-4-methyl-2H-chromen-2-one/ol;
DEAMPY, 2-(diethylamino)-6-methylpyrimidin-4-ol/one; DEDTP, diethyldithiophosphate; DMDTP, dimethyldithiophosphate; IMPY, 2-isopropyl-4-methyl-6-hydroxypyrimidine; MSMB,
methysulfonylmethylbenzazimide; X, exposure to the pesticide listed.
aSources on insecticidal uses from U.S. EPA. (2003)not converted to its oxon form, it can undergo
hydrolysis to its speciﬁc metabolite and dialkyl-
thionate metabolites (i.e., dialkylthiophosphate
and/or dialkyldithiophosphate). For chlorpyri-
fos, these metabolites are diethylthiophosphate
and TCPY. These metabolites and/or their
glucuronide or sulfate conjugates are excreted
in urine.
Biomarkers of Effect:
Monitoring Cholinesterase
Inhibition in Blood
Examining cholinesterase inhibition as a
biomarker of effect is one potential strategy.
Acetylcholine (ACh) transmits electrochemical
signals across neuronal synapses and neuro-
muscular junctions and is hydrolyzed by the
action of the enzyme AChE. A serine residue
with a free hydroxyl group in the active site of
AChE covalently reacts with ACh, acetylating
the serine while releasing the choline group.
Within microseconds, the serine residue is
deacetylated by hydrolysis and is free to
degrade another ACh molecule. OPs in the
oxon form (i.e., phosphate form) can react
similarly with the serine residue; however, the
dephosphorylation process is much slower,
along the order of hours to days, than that
for deacetylation (Karalliedde et al. 2001).
Therefore, the serine residue on the phospho-
rylated AChE is not available to break down
ACh. The toxic effects of OPs result from their
ability to inhibit the action of AChE in the
nervous system, causing a buildup of ACh,
overstimulating the nervous system (Karalliedde
et al. 2001). OP poisoning is diagnosed by
measuring reduced cholinesterase activity in red
blood cells (RBCs).
Although cholinesterase monitoring has
the advantage of providing a measure of physi-
ologic response, it has disadvantages as well.
Interpretation of AChE monitoring results is
complicated by inter- and intraindividual vari-
ation in enzymatic activity and confounding
factors such as cholinesterase suppression
resulting from health conditions, and/or expo-
sure to other cholinesterase-inhibiting pesti-
cides (e.g., carbamate pesticides; Bissbort et al.
2001; Lessenger and Reese 1999). Because of
ﬂuctuations in AChE levels, a baseline AChE
level is needed to determine if suppression has
occurred. Genetic inﬂuences not related to sex,
race, or age account for 23% of variation in
AChE activity levels among humans (Lessenger
and Reese 1999). AChE levels in children
younger than 4 months have been shown to be
lower than for adults, whereas levels in children
older than 4 months were comparable with
those of adults (Karlsen et al. 1981). Pregnancy,
diseases, medications, and illegal drugs affect
AChE levels in adults (De Peyster et al. 1993;
Lessenger and Reese 1999). Because of the
tremendous amount of variation in AChE due
to endogenous and exogenous variables, a mon-
itoring program that does not account for varia-
tion due to these factors will produce data that
will be difﬁcult, if not impossible, to interpret.
Another drawback of AChE monitoring is that
large doses are required for signiﬁcant AChE
inhibition to occur. Therefore, AChE monitor-
ing is used more appropriately as an indicator
of toxicity at high exposure levels and is rather
insensitive at low exposure levels (He 1999).
The inhibition of RBC AChE and plasma
cholinesterase (PChE) is highly correlated with
intensity and duration of exposure to OPs.
RBC AChE, the same molecular target as that
responsible for acute OP toxicity in the ner-
vous system, is a more speciﬁc indicator than is
PChE. However, a few of the OP compounds
(e.g., malathion, diazinon, and dichlorvos) are
earlier inhibitors of PChE than of AChE. In
this case, PChE might be a more sensitive indi-
cator of exposure than is AChE but may not be
associated with symptoms and signs of toxicity
(Jeyaratnam and Maroni 1994).
AChE measurements have been used
extensively in occupational monitoring of pes-
ticide applicators (Magnotti et al. 1988) but
have not been used widely in general popula-
tion exposure studies. The U.S. EPA considers
blood AChE inhibition data to be appropriate
for deriving reference doses or concentrations
as part of a weight of evidence analysis for pes-
ticide toxicity but notes that reliability of these
measures depends on the quality of the avail-
able data (U.S. EPA 2000).
The electrometric and colorimetric meth-
ods, which measure change in pH and light
absorbance, respectively, are used most often
to measure AChE suppression. Both methods
can be used to measure both serum and ery-
throcyte cholinesterases and are relatively sim-
ple, inexpensive, and reproducible (Vandekar
1980). Even with modern testing kits and
methods, the determination of serum and ery-
throcyte AChE activity levels depends greatly
on technician experience and skill. Aware of
such sources of error, California—the only
U.S. state requiring AChE testing for pesticide
applicators—requires laboratory certification
of its AChE analysts (CEPA 2002).
Because OPs are metabolized rapidly, there
is some potential benefit of a marker of bio-
logic effect (e.g., AChE suppression) that may
integrate exposure over a longer time frame.
However, children are generally believed to be
exposed to OPs at levels much lower than
encountered occupationally. Their exposure is
more likely to be intermittent or variable in
intensity, and they are not likely to have base-
line AChE levels available for comparison. All
of these factors make blood measurements of
AChE less viable as a biomarker for children’s
OP exposure.
A potential alternative measurement is
to measure the bound cholinesterase itself.
Researchers in the Netherlands have devel-
oped a sensitive analytic technique to accu-
rately measure butyrylcholinesterase bound to
organophosphate nerve agents (Fidder et al.
2002). Their technique involves the enzymatic
Children’s Health | Biomarkers to indicate children’s exposure to OPs
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Figure 1. Metabolism of chlorpyrifos. Chemicals enclosed in boxes are excreted in the urine.
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CH3CH2Odigestion of butyrylcholinesterase to form a
nonapeptide. The amount of the phosphory-
lated peptide is quantiﬁed relative to the non-
phosphorylated peptide. Using this method,
exposure could be detected at levels that
caused only about 1% suppression of choli-
nesterase activity—a level much too low to
detect using standard cholinesterase assays.
This measurement would likely reflect the
clinically relevant dose for acute toxicity, but it
is less clear whether this method would pro-
vide a useful biomarker for potential OP-
related health effects that may not rely on this
mechanism of action.
Biomarkers of Exposure:
Monitoring Pesticides 
and/or Metabolites in 
Biologic Samples
Blood. Monitoring OP concentrations in
blood or blood products (e.g., serum, plasma)
offers several advantages. The parent com-
pounds can be monitored directly in blood
products instead of their metabolites, which
are usually measured in urine. Therefore,
detailed information regarding the metabolism
of the pesticide is less critical, and toxicant
concentrations for specific OPs are known
rather than inferred from metabolites. This
information is especially beneficial because
not all OPs are equally toxic. Blood measure-
ments provide an estimation of the dose avail-
able for the target site, allowing for prediction
of dose–response relationships. Furthermore,
because blood is a regulated fluid (i.e., the
volume does not vary substantially with water
intake or other factors), the blood concentra-
tions of toxicants measured at a speciﬁed time
interval after exposure will remain the same as
long as the absorbed amounts are constant;
therefore, no corrections for dilution are nec-
essary. Blood concentrations of the toxicant
are often at a maximum directly after expo-
sure, so if exposure events are known, the pre-
ferred time range for sampling may be clearer
than with urine. However, in a large study
such as the NCS, biologic sample collection
will likely be based on other considerations
(e.g., clinic visits) rather than occurrence of
an exposure event.
The major disadvantages related to blood
measurements are the venipuncture and associ-
ated risks (e.g., bruising, discomfort) required
to obtain the sample, and the analytic challenge
of measuring low toxicant concentrations. If
available, umbilical cord blood can overcome
some of these concerns for measuring recent
in utero exposures, because venipuncture is not
needed and relatively large quantities of blood
(> 30 mL) can be collected. The invasive
nature of venipuncture puts some limits on
researchers’ ability to obtain samples from
children and pregnant women or to get high
participation rates in large-scale studies. In
addition, the amount of blood available to
perform the analysis is often limited; therefore,
ultrasensitive analytic techniques may be
required. Analysis is further complicated by
the inherently low concentrations of OPs
present in the blood (typically seen in the
nanogram per liter or parts per trillion range)
when compared with urinary metabolite con-
centrations (typically seen in the microgram
per liter or parts per billion range).
Several laboratory methods have been
reported that measure intact OPs in blood
(Fournier et al. 1978; Frenzel et al. 2000;
Kawasaki et al. 1992; Liu et al. 1989; Maroni
et al. 1990; Marques 1990; Meyer et al. 1998;
Sharma et al. 1990). Unfortunately, most of
these methods have limits of detection
(LODs) that would prevent their use in mea-
suring incidental exposures. For example,
Frenzel et al. (2000) reported a method to
measure methamidophos and methyl para-
thion in blood with LODs of about 25 µg/L.
However, data reported by Whyatt et al.
(2003) indicate that levels in pregnant women
and cord blood were about 3 orders of magni-
tude lower. Recent advances in analytic instru-
mentation have facilitated the development of
highly sensitive methods (Barr et al. 2002; Liu
and Pleil 2002); however, these methods are
often complicated and costly, precluding their
use for routine analysis.
Urine. An obvious advantage of biologic
monitoring in urine is the ease of sample col-
lection, the high concentration of analytes, and
the greater amount of sample available for
analysis compared with blood. However, these
advantages may be diminished somewhat for
infants and very small children for whom urine
collection procedures require special considera-
tion. Appropriate sample collection apparatus,
such as urine collection bags or toilet inserts,
must be provided to collect urine samples from
children who are not toilet trained.
One of the disadvantages of urinary analy-
sis is that urine output varies. Many factors
inﬂuence daily urinary output, such as water,
urea, salt, specific gravity, and osmolality.
Consequently, the concentration of toxicants or
metabolites may vary, even if the internal dose
remains constant. For this reason, either 24-hr
urine samples must be obtained for analysis, or
“spot” or “grab” samples must be corrected for
dilution. Because 24-hr urine samples are not
practical in large-scale population-based studies
of children, spot samples or first morning
voids (for more concentrated samples) can be
obtained, and their concentration normalized
using creatinine (CRE) concentration or spe-
cific gravity. However, CRE yield has been
shown to be variable among children (Freeman
et al. 1995; O’Rourke et al. 2000). Metabolite
results are considered questionable for samples
with CRE < 0.3 or > 3.0 g/L (Lauwerys and
Hoet 1993; O’Rourke et al. 2000; WHO
1996); however, no data are reported on which
these limits are based. Furthermore, because
CRE excretion depends on muscle mass, chil-
dren inherently excrete less CRE. In fact, about
35% of the children’s samples analyzed at the
Centers for Disease Control and Prevention
(CDC) had CRE concentrations less than
0.3 g/L (CDC. Unpublished data). This makes
comparisons between CRE-adjusted adults’ and
children’s urinary toxicant concentrations sub-
ject to great error because of “overcorrection” of
children’s samples.
An alternative though less widely used
method for adjusting urine dilution is based on
urinary speciﬁc gravity. Speciﬁc gravity mea-
surements take into account all solids dissolved
in a urine sample, not just CRE. Typically,
urine samples are adjusted to a speciﬁc gravity
of 1.024. Additional research is required to
determine whether this is a viable alternative
for routine urinary adjustments.
Variations in metabolite concentrations
due to changing water content in urine can
also be eliminated using urinary excretion rate
calculations (Rigas et al. 2001). However,
because the void volume and times of previous
and current void are required, this approach
may not be practical for young children.
Of the OPs registered with the U.S. EPA
for use in the United States, about 75%
metabolize to form from one to three of the six
DAP metabolites. These six metabolites are
dimethylphosphate (DMP), dimethylthiophos-
phate (DMTP), dimethyldithiophosphate,
diethylphosphate (DEP), diethylthiophosphate
(DETP), and diethyldithiophosphate. The OP
pesticides registered with the U.S. EPA and their
potential common metabolites are listed in
Table 1. Pesticide-speciﬁc information cannot
be derived from the quantitative measurement
of these metabolites; however, a cumulative dose
measure of OPs as a class of pesticides can be
obtained.
The pesticide-speciﬁc metabolites can also
be measured. The quantitative measurement of
these metabolites provides a measure of dose
for a speciﬁc pesticide. For instance, the mea-
surement of TCPY provides dose information
speciﬁc to chlorpyrifos or chlorpyrifos-methyl.
It is important to note that not all pesticide-
specific metabolites are derived solely from
OPs. For example, 4-nitrophenol, a specific
metabolite of parathion or methyl parathion, is
also a widely used chemical and can enter the
body from other exposure sources.
Measurements of either the common OP
metabolites or the specific metabolites have
advantages and disadvantages. Both the com-
mon and specific metabolites are also the
hydrolysis or breakdown products of OPs in
environmental media (Heudorf and Angerer
2001). Therefore, the measured concentra-
tions of these metabolites can result from
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products in environmental media. The com-
mon metabolite measurements provide class-
specific data that take into account not only
aggregate exposures (i.e., exposure to a single
pesticide from multiple sources) but also
cumulative exposures (i.e., exposure to two or
more pesticides with the same mechanism of
toxicity). However, because individual pesti-
cides differ in acute toxicities, these data are
not good indicators of the toxicity of the
cumulative dose. DAPs may be metabolites of
some industrial chemicals and rare pharma-
ceuticals, but it is generally believed that most
DAPs result from OP exposure or exposure to
OP hydrolysis products (Barr et al. 2002).
The DAP data can be used to “screen” for
total OP exposure, and follow-up analyses of
the specific metabolites can be performed if
the common metabolites levels appear ele-
vated. In addition, these data can help distin-
guish between the individual pesticides in OP
pairs (e.g., methyl parathion from parathion,
chlorpyrifos from chlorpyrifos-methyl).
The specific metabolite measurements
provide dose data on individual pesticides.
However, because of the large number of OPs,
the chemical nature of some of the OP metabo-
lites, and the lack of availability of analytic
standards, it is not feasible to measure all of the
specific metabolites at this time. Therefore,
cumulative data cannot be obtained from spe-
cific metabolite measurements because so
many metabolites cannot be measured. We
believe that the data obtained from measuring
both the common and specific metabolites,
where available, complement each other.
Together, these data can provide the most
complete OP internal dose information.
Urine metabolite levels are generally con-
sidered a much more sensitive and specific
indicator of OP exposure than is AChE moni-
toring, and have been reported in several stud-
ies of children (Adgate et al. 2001; Aprea et al.
2000; Fenske et al. 2002; Loewenherz et al.
1997; Lu et al. 2001; Mills and Zahm 2001;
Moate et al. 1999; O’Rourke et al. 2000).
DAPs can be detected in urine at exposure lev-
els below those affecting cholinesterase activity
(Coye et al. 1986). However, because all OPs
differ in toxicity, the measured DAP levels are
not direct measures of toxicologic potential.
It is necessary to understand the kinetics of
metabolite excretion to know the optimum
time for urine collection (Grifﬁn et al. 1999).
Also, not all OPs are metabolized to a measur-
able level of DAPs; therefore, exposure may
occur but not be detected by current labora-
tory methods. Because of variation in meta-
bolic rates from individual to individual,
optimal sampling times will vary. OPs are
metabolized and preferentially excreted in the
urine usually within 24–48 hr of exposure
(WHO 1996).
At least seven laboratories in North
America and Europe are routinely analyzing
DAPs in epidemiologic studies. These labora-
tories use methodologies usually developed in-
house and employ gas chromatography with
some sort of selective detection technique such
as nitrogen-phosphorus detection or mass
spectrometric detection. The LODs of these
methods are in the low picrogram to the low
nanogram per millimeter range. Surprisingly,
even though so many laboratories are measur-
ing these DAP concentrations in a variety of
studies and are reporting the values in peer-
reviewed literature, the first interlaboratory
comparison of analyses was performed just
recently. To confirm that data originating
from the various laboratories are directly com-
parable, the U.S. EPA initiated an interlabora-
tory comparison study among the North
American laboratories performing DAP analy-
ses. The results of this study will allow us to
determine whether results across laboratories
are comparable; and if they are not, it will
allow us to standardize methodologies to pro-
mote harmonization among laboratory data.
Several studies have shown higher DAP
levels in children than adults. In a study of
1,194 subjects in Germany, Heudorf and
Angerer (2001) found significantly higher
metabolite concentrations per gram of CRE
in children younger than 6 years than in any
other age group (6 to < 14 years, 14 to < 20
years, ≥ 20 years). The researchers concluded
that this was a result of the children’s lower
urinary CRE content, but allowed that chil-
dren’s exposure may still be higher than that
of adults. In a study of farmworkers and their
children in California, Mills and Zahm
(2001) found DMP, DMTP, and DETP
more often in the urine of children than in
that of their farmworker parents. However,
DEP was detected more frequently among
adults than among children. A study of 195
Italian children found signiﬁcantly higher val-
ues of all OP metabolites in children than in
124 adults sampled in a previous study in a
nearby region (Aprea et al. 2000).
Specific OP metabolites have also been
measured in several studies involving chil-
dren. In the Minnesota Children’s Pesticide
Exposure Study (MNCPES), higher levels of
TCPY were found among urban children
than among those living in nonurban areas
(Adgate et al. 2001). Malathion dicarboxylic
acid showed a similar, although only margin-
ally signiﬁcant, trend among this study popu-
lation. Fenske et al. (2002) measured both
TCPY and para-nitrophenol, a metabolite of
parathion, methyl parathion, and other chem-
icals, in the urine of children of farmworkers
and pesticide applicators. Although the mean
urinary concentrations of both metabolites
were greater in children living within 200 feet
of pesticide-treated farmland, these differences
were not statistically signiﬁcant. MacIntosh et
al. (2001) found that dietary chlorpyrifos lev-
els were signiﬁcantly correlated with mean uri-
nary TCPY excretion in the National Human
Exposure Assessment Survey in Maryland and
that the dietary chlorpyrifos accounted for
approximately 7% of the urinary TCPY.
Meconium. Only recently has the use of
meconium been investigated as a potential
matrix for testing of exposure to OPs.
Meconium has previously been used to identify
fetal exposure to illicit drugs, alcohol, and
tobacco (Bearer et al. 1999; Browne et al.
1994; Callahan et al. 1992; Clark et al. 1992;
Dempsey et al. 1999; Maynard et al. 1991;
Moore et al. 1998; Ostrea 1999; Ryan et al.
1994) as well as the more persistent environ-
mental toxicants, such as organochlorines and
heavy metals (Hong et al. 2002; Ramirez et al.
2000). Meconium begins to accumulate in the
bowels of human fetuses at approximately
16 weeks gestation and is generally not
excreted until after delivery (Moriya et al.
1994). Meconium is a complex matrix, con-
sisting mainly of water but also containing
mucopolysaccharides, lipids, proteins, bile
acids and salts, epithelial cells, cholesterol and
sterol precursors, blood-group substances,
squamous cells, residual amniotic fluid, and
enzymes (Moore et al. 1998). Xenobiotics
appear to enter the meconium as a conse-
quence of bile excretion into the intestines
and/or of swallowing of amniotic ﬂuid by the
fetus (Ostrea et al. 1993). Evidence suggests
that the half-life of xenobiotics in meconium
can be protracted and that measured levels may
reﬂect exposures from the second trimester of
pregnancy through delivery (Bearer et al. 1999;
Ostrea 1999).
Whyatt and Barr (2001) analyzed 20 meco-
nium samples from newborns and found some
level of OP metabolites in all 20 samples. The
researchers concluded that measurement of OP
metabolites in meconium showed promise as a
biomarker of prenatal exposure. Detection lim-
its for the OP metabolites were low and compa-
rable with or better than those seen with adult
urine. One of the biggest advantages of meco-
nium analysis is the ease and noninvasive nature
of meconium collection. Whyatt and Barr
(2001) also found that pesticide metabolites
were stable in meconium for more than 12 hr
at room temperature. Given these initial
promising ﬁndings, further research is needed
to determine the time frame of exposure repre-
sented by pesticide levels in meconium and
evaluate the dose–response relationship
(Whyatt and Barr 2001). Additionally, the
same issues as for urinary analysis must be
addressed in meconium analysis, such as kinet-
ics of metabolism, pass-through of metabolites,
normalization of measured concentrations on
water content, and establishment of reference
concentrations.
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Given the scope, complexity, and magnitude of
the NCS, one cost-effective, time-saving strat-
egy to assess potential health effects associated
with OP exposure would be to devise a screen-
ing method to identify and oversample the
most highly exposed children. Identiﬁcation of
more highly exposed children would limit the
number of results reported below detection
and/or quantiﬁcation limits of analytic meth-
ods. Limited evidence exists to identify chil-
dren at higher risk for OP exposure, and a
recent report from the MNCPES highlights
the challenges of screening for general pesticide
use when specific target compounds are of
interest (Sexton et al. 2003). The following
groups have been identiﬁed as having higher
urinary biomarker levels for OPs: children of
pesticide applicators (Loewenherz et al. 1997),
younger children within the 0–6 year age range
(Loewenherz et al. 1997), children living closer
to pesticide-treated orchards (Loewenherz et al.
1997), children living in urban areas (Adgate et
al. 2001), and those living where pesticides are
used inside or outside the home (Aprea et al.
2000; Lu et al. 2001). In a study such as the
NCS, a ﬁrst step might include questionnaire
data to indicate the likelihood that the child is
exposed and a qualitative ranking of the expo-
sure (e.g., low, moderate, high). Biologic sam-
pling could then be targeted at specifically
ranked groups rather than applied to everyone
with the same intensity. Where chemical
analyses are resource intensive, other strategies
can be used. If compounds are stable after
long-term storage, then specimens can be ana-
lyzed case by case for children in special stud-
ies, such as nested case–control studies of
childhood diseases. Callahan et al. (1995) dis-
cuss statistical methods and issues regarding
stratiﬁcation and oversampling for target popu-
lations that could be used to evaluate health
risks associated with low-level or infrequent
exposures.
The MNCPES is an example of a study
conducted in this manner. The MNCPES
used a probability-based sampling strategy to
identify and oversample children who were
potentially exposed to targeted pesticides
(Quackenboss et al. 2000). Using probability-
based sampling reduced the potential for a
selection bias, allowed the calculation of
weighted population statistics, and allowed the
results to be generalized to the population.
The MNCPES was conducted in three phases:
a) identiﬁcation of households with age-eligi-
ble children (3–12 years) and more frequent
pesticide use, b) screening of households
selected in phase 1 using a questionnaire and
an inventory of pesticide product storage and
use, and c) intensive monitoring of the chil-
dren with the highest potential for exposure as
identified in phase 2. Whether or not the
NCS is a probability sample, sampling units
can still be derived to enhance the internal
validity of OP exposure measurements based
on identifying highly exposed children and
subsets of children with lower levels of expo-
sure for comparison purposes.
Current Research and Future
Research Needs
Much research is currently in progress to evalu-
ate children’s exposure to OPs, health effects
resulting from OP exposure, and other biologic
monitoring methods. For example, many
of the jointly funded National Institute of
Environmental Health Sciences/U.S. EPA
Centers for Children’s Environmental Health
and Disease Prevention Research are conduct-
ing studies in which women are enrolled dur-
ing early pregnancy and their children are
followed for the first several years of life
(Castorina et al. 2003). These studies will fur-
ther deﬁne current OP exposure levels in chil-
dren, help determine the most appropriate
matrix or matrices for exposure measurements,
facilitate the development of additional bio-
monitoring methods, provide information
about the frequency of collections needed to
estimate chronic exposures and to detect acute
or peak exposures for individuals, evaluate
and/or validate questionnaires, and elucidate
health end points (e.g., neurodevelopment,
growth, and respiratory health). A great deal of
research related to OP biomarkers in blood,
urine, and other matrices remains to be com-
pleted before the NCS begins. Research needs
for each of the currently available biomonitor-
ing methods are discussed below.
To identify speciﬁc OP concentrations in
blood, laboratory analysis methods must be
developed for all OPs currently registered for
use in the United States or having allowable tol-
erances on imported food products (Table 1).
This may not be a feasible expectation, given
the chemical properties of the particular pesti-
cides; however, it is still a critical need for a
comprehensive OP exposure assessment. A
long-term study such as the NCS will then
have the information needed to develop dose–
response curves, correlating health end points
with measured toxicant concentrations.
Research is needed to identify physical
and biologic mechanisms of degradation of
OPs and fate of metabolites in the environ-
ment and in the human body. OPs degrade in
foodstuff before ingestion, but the amount of
these metabolites and any biologic effect they
might have as they pass through the human
body are unknown. Currently, the U.S. EPA
and the CDC are jointly engaged in research
to identify the relative contributions of expo-
sure to environmental degradation products
to urinary metabolite levels. Multiroute (e.g.,
duplicate diet, dust, and air) environmental
exposures are being measured for both intact
pesticides and their degradation products as
well as monitoring blood, urine, and saliva.
These data should help us understand better
the potential confounding of biomarker data
from exposure to pesticides with exposure to
the environmental degradates.
Easier, less costly, but still high-quality
laboratory methods for DAP measurements
would allow more samples to be analyzed in
less time. Currently, the specific metabolites
for only 10 OPs have been measured in urine
(Table 1). Identiﬁcation of speciﬁc metabolic
products for each OP, if possible, would allow
the use of urine, an easier matrix to obtain than
blood, in prediction of dose–response curves.
Research to establish the half-life for each OP
would allow better estimation of the appropri-
ate sampling time frame during human studies
and allow for dose estimations.
Further research is needed to establish ref-
erence-range CRE concentrations based on
age, race, sex, and seasonal variation. Research
of specific gravity (and/or osmolality) would
indicate whether it is a viable alternative to
adjust for urine dilution.
Use of postpartum meconium shows
promise, and further research could firmly
establish it as a biomarker for OP exposure.
Research is needed to determine the time
frame of exposure represented by metabolite
levels, kinetics of metabolism, fate of metabo-
lites, best methods to normalize measured
concentrations on water content, and refer-
ence concentrations.
It would be valuable to know if there is sig-
niﬁcant degradation of the parent compounds
and/or metabolites in biologic samples over
time and how storage conditions are related to
potential degradation. Many important expo-
sure–health outcome studies may be done after
years of specimen storage—for example, nested
case–control studies to evaluate the potential
risk of early life pesticide exposures associated
with an uncommon child health outcome.
Conclusions
Biomarkers are an effective way to determine
exposure to OPs, particularly for known
exposure events. A challenge of all monitoring
methods discussed here is that OPs are so
rapidly metabolized and excreted. It is vital
for investigators to consider the relationship
between the exposure time frame reﬂected in
an OP biomarker and the research questions.
It would not be advisable to assume that bio-
logic measures of OP exposure levels are rela-
tively constant over time.
In a longitudinal study, to characterize
intermittent exposures as well as the chronic
background OP level, repeated biologic sam-
ples may be needed. Specimens could be col-
lected at a number of potential contact points
where OP exposure could be assessed, such as
clinical exams to assess child development and
routine prenatal visits. Those analyses should
Children’s Health | Wessels et al.
1944 VOLUME 111 | NUMBER 16 | December 2003 • Environmental Health Perspectivesbe conducted if the investigators believe the
time frame is important or representative of a
vulnerable period in child development, recog-
nizing that the spot sample cannot provide an
integrated measure of exposure over time.
Critical windows of vulnerability in the devel-
oping child have been identified for many
health outcomes (Selevan et al. 2000). When
the relevant exposure time frame is known,
researchers can try to obtain biologic specimens
during those time windows. Alternatively,
research questions about exposure events, such
as accidental poisoning or nearby agricultural
spraying, may be used to develop protocols
that bring children in after an acute event and
follow them to observe potential effects.
For hypotheses that relate in utero expo-
sure to child health outcomes, meconium
may give an integrated measure that probably
reflects aggregate OP exposure over the sec-
ond half of pregnancy. This time frame is
important for many child health end points
but would not directly cover birth defects or
other outcomes with first-trimester origins.
Maternal samples collected prenatally might
also provide an indication of short-term acute
fetal exposure. Maternal blood samples col-
lected at delivery have OP levels that correlate
well with those measured in their umbilical
cord blood (Whyatt et al. 2003), suggesting
that maternal pesticide levels may accurately
reﬂect the dose being transported to the fetus
through the placenta.
Measurement of AChE in blood is not
currently a viable method for monitoring
long-term, low-level exposure in children.
However, monitoring specific OPs in blood
offers useful information because health end
points can be correlated to specific toxicant
concentrations. A powerful tool will be avail-
able once laboratory methods have been devel-
oped to measure all OPs used in the United
States. In the meantime, measurement of
speciﬁc metabolites in blood used in concert
with urine metabolite measurements (general
and specific) will allow for prediction of
dose–response relationships for many of the
OPs. Some research questions may be more
conﬁdently answered with other measures of
usual or typical exposure, such as residential
pesticide use or time–activity questionnaires.
If the relevant time frame for exposure is
past or uncertain, the utility of a one-time
measurement for OP biomarkers is question-
able. Most OP biomarkers reﬂect recent expo-
sure via all pathways over a very short time
frame, from several hours to days. One-time
biomarker measures could be useful in popu-
lations of children with relatively stable back-
ground levels of OP exposure. Children who
are subject to exposure variation associated
with intermittent uses, such as in agricultural
areas or periodic residential applications, are
likely to be poorly classified on the basis of
one spot measurement. As we learn more
about the contribution of various sources of
exposure for children, we may be better able to
identify groups of children that can be classi-
fied accurately using OP biomarkers. Unless
the researchers have some conﬁdence about the
relation between the historical and current lev-
els of exposure, a biomarker of current expo-
sure might prove misleading.
Lack of precision and potential misclassiﬁ-
cation of exposure are common shortcomings
in environmental epidemiology. Although this
limitation can be easily overcome when the
risk relationships under study are robust or the
exposures are relatively uncommon, it is a
greater challenge for exploratory investigations
of health effects associated with ubiquitous,
low-level exposures such as a typical child’s
OP exposure scenario. Answering current
research questions on the stability of stored
samples over time, interlaboratory analytic
comparisons, and further descriptions of the
characteristics of children and families where
exposures are more common and more stable
over time will help us determine the appropri-
ate strategies for incorporating OP biomarkers
into the NCS.
As in any observational study where the
participants receive little direct beneﬁt, biologic
specimens represent a signiﬁcant contribution
of the participants toward the advancement of
science and the public good. These contribu-
tions should be used to enhance hazard identi-
ﬁcation and elucidate risk relationships where
the underlying scientiﬁc rationale suggests they
will be of greatest public health benefit.
Biomarkers of OP exposure can be a valuable
tool in epidemiology of children’s environmen-
tal health. They can improve exposure assess-
ment and reduce misclassification, thereby
strengthening our conﬁdence in any exposure–
outcome relationships observed. The challenge
is to apply and interpret those biomarkers
appropriately.
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